Pediatric PET/MR Image Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 40
SponsorStanford University
About this trial
The purpose of this study is to compare whole body magnetic resonance (MR) imaging, whole body positron emission tomography (PET)/MR imaging, and (if available) PET/Computed Tomography (CT) imaging for the diagnosis of tumors in children and young adults. Sensitivities, specificities and diagnostic accuracies of the different imaging modalities will be compared for significant differences.
Eligibility criteria
Qualifiers
Patients with proven solid tumors or newly diagnosed mass strongly suspected to represent a solid tumor.
We might also include some patients with leukemia if there is concern for a focal lesion in any of their organs.
Participant's parents (if participant is under 18) or the participant (if participant is 18 years or older) must willingly give written informed consent prior to any image transfer to the image registry.
Disqualifiers
Patient has contraindications for MRI or PET/MR. This includes patients with cardiac pacemakers or intracranial vascular clips as well as patients with a blood glucose level > 200 mg/dl.
Lack of parental permission (if participant is younger than 18) or lack of informed consent (if participant is at least 18 years of age).
Patient has a CNS primary tumor.
Pregnant women and fetuses
Trial design
Treatments tested in this trial
- PET/MR imaging
- MR imaging
- PET/CT imaging
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Stanford University
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov